Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dyslipidemia

Free Subscription Articles published in Metabolism Retrieve available abstracts of 10 articles: HTML format

Single Articles

July 2025
1. WANG Y, Wu Y, Jiang H, Li S, et al
   L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and ovarian dysfunction in polycystic ovary syndrome.
   Metabolism. 2025;168:156238.
   PubMed     Abstract available
   
   
   March 2025
2. DE MOURA DE SOUZA M, Mendes BX, Defante MLR, de Athayde de Hollanda Morais BA, et al
   Apolipoprotein C-III inhibitors for the treatment of hypertriglyceridemia: A meta-analysis of randomized controlled trials.
   Metabolism. 2025 Mar 10:156187. doi: 10.1016/j.metabol.2025.156187.
   PubMed     Abstract available
   
   
   November 2024
3. CONGUR I, Mingrone G, Guan K
   Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy.
   Metabolism. 2024 Nov 6:156062. doi: 10.1016/j.metabol.2024.156062.
   PubMed     Abstract available
   
   
   September 2024
4. JEONG JH, Kim YG, Han KD, Roh SY, et al
   Association of fatty liver index with sudden cardiac arrest in young adults.
   Metabolism. 2024;158:155981.
   PubMed     Abstract available
   
   
   
5. DANPANICHKUL P, Suparan K, Dutta P, Kaeosri C, et al
   Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
   Metabolism. 2024;158:155958.
   PubMed     Abstract available
   
   
   July 2024
6. HAGVE M, Pereira SL, Walker DK, Engelen MPKJ, et al
   Statin treatment reduces leucine turnover, but does not affect endogenous production of beta-hydroxy-beta-methylbutyrate (HMB).
   Metabolism. 2024;156:155920.
   PubMed     Abstract available
   
   
   June 2024
7. EZHILARASAN D
   Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha/gamma agonist for managing metabolic NAFLD.
   Metabolism. 2024;155:155912.
   PubMed     Abstract available
   
   
   April 2024
8. ZELJKOVIC A, Vekic J, Stefanovic A
   Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
   Metabolism. 2024;156:155919.
   PubMed     Abstract available
   
   
   November 2023
9. ZUO F, Wang Y, Xu X, Ding R, et al
   CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
   Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
   PubMed     Abstract available
   
   
   July 2023
10. WANG YD, Wu LL, Mai YN, Wang K, et al
    miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.